JDOC vs. CNCR

Last updated Jun 24, 2026

JDOC (Jpmorgan Healthcare Leaders ETF) and CNCR (Loncar Cancer Immunotherapy ETF) are both Health & Biotech Equities funds. JDOC is actively managed, while CNCR is passively managed. JDOC charges 0.65%/yr vs 0.79%/yr for CNCR.

Performance

JDOC vs. CNCR - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Jpmorgan Healthcare Leaders ETF (JDOC) and Loncar Cancer Immunotherapy ETF (CNCR). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

JDOC

• 1D: 1.11%
• 1M: 2.00%
• YTD: -0.08%
• 6M: -0.49%
• 1Y: 17.29%
• 3Y*: —
• 5Y*: —
• 10Y*: —

CNCR

• 1D: 0.00%
• 1M: 0.00%
• YTD: —
• 6M: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

JDOC vs. CNCR - Yearly Performance Comparison

	2026 (YTD)
JDOC Jpmorgan Healthcare Leaders ETF	-0.08%
CNCR Loncar Cancer Immunotherapy ETF	0.00%

JDOC vs. CNCR - Sectors Allocation Comparison

Sectors	JDOC	CNCR
Healthcare	100.0%	96.6%
Basic Materials	-	-
Communication Services	-	-
Consumer Cyclical	-	-
Consumer Defensive	-	-
Energy	-	-
Financial Services	-	3.3%
Industrials	-	-
Real Estate	-	-
Technology	-	-
Utilities	-	-

Return for Risk

JDOC vs. CNCR — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

JDOC

JDOC Risk / Return Rank: 36
JDOC Sharpe Ratio Rank: 36
JDOC Sortino Ratio Rank: 39
JDOC Omega Ratio Rank: 34
JDOC Calmar Ratio Rank: 38
JDOC Martin Ratio Rank: 33

CNCR

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

JDOC vs. CNCR - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Jpmorgan Healthcare Leaders ETF (JDOC) and Loncar Cancer Immunotherapy ETF (CNCR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	JDOC	CNCR	Difference
Sharpe ratio: Return per unit of total volatility	1.21	—	—
Sortino ratio: Return per unit of downside risk	1.92	—	—
Omega ratio: Gain probability vs. loss probability	1.22	—	—
Calmar ratio: Return relative to maximum drawdown	1.79	—	—
Martin ratio: Return relative to average drawdown	4.54	—	—

Drawdowns

JDOC vs. CNCR - Drawdown Comparison

The maximum JDOC drawdown since its inception was -20.87%, which is greater than CNCR's maximum drawdown of 0.00%. Use the drawdown chart below to compare losses from any high point for JDOC and CNCR.

Drawdown Indicators

	JDOC	CNCR	Difference
Max Drawdown Largest peak-to-trough decline	-20.87%	0.00%	-20.87%
Max Drawdown (1Y) Largest decline over 1 year	-9.68%	—	—
Current Drawdown Current decline from peak	-3.20%	0.00%	-3.20%
Average Drawdown Average peak-to-trough decline	-6.93%	0.00%	-6.93%
Ulcer Index Depth and duration of drawdowns from previous peaks	3.81%	—	—

Volatility

Volatility by Period

	JDOC	CNCR	Difference
Volatility (1M) Calculated over the trailing 1-month period	5.26%	—	—
Volatility (6M) Calculated over the trailing 6-month period	10.56%	—	—
Volatility (1Y) Calculated over the trailing 1-year period	14.35%	0.00%	+14.35%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	14.52%	0.00%	+14.52%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	14.52%	0.00%	+14.52%

JDOC vs. CNCR - Expense Ratio Comparison

JDOC has a 0.65% expense ratio, which is lower than CNCR's 0.79% expense ratio.

Dividends

JDOC vs. CNCR - Dividend Comparison

JDOC's dividend yield for the trailing twelve months is around 0.89%, while CNCR has not paid dividends to shareholders.

Position	TTM	2025	2024	2023
CNCR Loncar Cancer Immunotherapy ETF	0.00%	0.00%	0.00%	0.00%
JDOC Jpmorgan Healthcare Leaders ETF	0.89%	0.89%	5.57%	0.15%

Frequently Asked Questions

Which ETF is better, JDOC or CNCR?

On fees, JDOC is cheaper at 0.65% per year. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF is cheaper, JDOC or CNCR?

JDOC is cheaper with a 0.65% expense ratio, compared with 0.79% for CNCR.

Which ETF pays a higher dividend yield, JDOC or CNCR?

JDOC has the higher dividend yield at 0.89%, compared with 0.00% for CNCR.

What is the main difference between JDOC and CNCR?

They also come from different issuers: JPMorgan and Exchange Traded Concepts. Their fees differ too: 0.65% for JDOC and 0.79% for CNCR.